GPR119 Agonist for Hypoglycemia inType1Diabetes (PHROG) study
<p dir="ltr">A randomized controlled trial of GPR119 agonist on glucagon response in Type 1 diabetes.</p><p dir="ltr">This is a randomized placebo-controlled, double-blinded, within-subject, cross-over phase 2a study. Participants are randomly assigned to placeb...
Sábháilte in:
| Príomhchruthaitheoir: | |
|---|---|
| Foilsithe / Cruthaithe: |
2025
|
| Ábhair: | |
| Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|